New Zealand markets open in 1 hour 42 minutes

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.4950+0.2850 (+23.55%)
At close: 03:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.73B
Enterprise value 10.41B
Trailing P/E 10.31
Forward P/E 8.10
PEG ratio (5-yr expected) 1.44
Price/sales (ttm)0.15
Price/book (mrq)0.56
Enterprise value/revenue 0.28
Enterprise value/EBITDA 8.57

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-23.72%
S&P500 52-week change 328.04%
52-week high 32.0000
52-week low 31.2100
50-day moving average 31.3831
200-day moving average 31.4583

Share statistics

Avg vol (3-month) 31.06k
Avg vol (10-day) 3200
Shares outstanding 5919.07M
Implied shares outstanding 65.84B
Float 81.65B
% held by insiders 124.01%
% held by institutions 123.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.08
Forward annual dividend yield 45.66%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 333.88%
5-year average dividend yield 4N/A
Payout ratio 458.80%
Dividend date 321 Aug 2017
Ex-dividend date 418 Jul 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.43%
Operating margin (ttm)3.39%

Management effectiveness

Return on assets (ttm)2.42%
Return on equity (ttm)6.27%

Income statement

Revenue (ttm)264.22B
Revenue per share (ttm)71.53
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
EBITDA 9.51B
Net income avi to common (ttm)3.79B
Diluted EPS (ttm)0.1500
Quarterly earnings growth (yoy)1.60%

Balance sheet

Total cash (mrq)37.18B
Total cash per share (mrq)10.04
Total debt (mrq)55.3B
Total debt/equity (mrq)67.36%
Current ratio (mrq)1.34
Book value per share (mrq)18.92

Cash flow statement

Operating cash flow (ttm)2.38B
Levered free cash flow (ttm)-3.5B